[go: up one dir, main page]

AU2001288431A1 - Detection of anti-glycolipid antibodies by latex agglutination assay - Google Patents

Detection of anti-glycolipid antibodies by latex agglutination assay

Info

Publication number
AU2001288431A1
AU2001288431A1 AU2001288431A AU8843101A AU2001288431A1 AU 2001288431 A1 AU2001288431 A1 AU 2001288431A1 AU 2001288431 A AU2001288431 A AU 2001288431A AU 8843101 A AU8843101 A AU 8843101A AU 2001288431 A1 AU2001288431 A1 AU 2001288431A1
Authority
AU
Australia
Prior art keywords
detection
latex agglutination
agglutination assay
glycolipid antibodies
glycolipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288431A
Other languages
English (en)
Inventor
Armin Alaedini
Norman Latov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Publication of AU2001288431A1 publication Critical patent/AU2001288431A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08—Sphingolipids
    • G01N2405/10—Glycosphingolipids, e.g. cerebrosides, gangliosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001288431A 2000-08-28 2001-08-28 Detection of anti-glycolipid antibodies by latex agglutination assay Abandoned AU2001288431A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64922900A 2000-08-28 2000-08-28
US09649229 2000-08-28
PCT/US2001/026708 WO2002018950A1 (fr) 2000-08-28 2001-08-28 Detection d'anticorps anti-glycolipides par detection de l'agglutination au latex

Publications (1)

Publication Number Publication Date
AU2001288431A1 true AU2001288431A1 (en) 2002-03-13

Family

ID=24603936

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288431A Abandoned AU2001288431A1 (en) 2000-08-28 2001-08-28 Detection of anti-glycolipid antibodies by latex agglutination assay

Country Status (2)

Country Link
AU (1) AU2001288431A1 (fr)
WO (1) WO2002018950A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1367395A1 (fr) 2002-05-02 2003-12-03 B.R.A.H.M.S Aktiengesellschaft Diagnostic des néoplasmes utilisant des anticorps anti-gangliosides
EP1369118A1 (fr) * 2002-06-04 2003-12-10 B.R.A.H.M.S Aktiengesellschaft Procédé et agent pour ls prevention, inhibition et thérapie de sepsie
EP1369693A1 (fr) * 2002-06-04 2003-12-10 B.R.A.H.M.S Aktiengesellschaft Procédé pour le diagnostic de la septicémie et le contrôle du sang des doneurs en utilisant des anticorps anti-asialo gangliosides
MXPA05001270A (es) 2002-08-02 2005-08-03 Glycominds Ltd Metodo para diagnostico de esclerosis multiple.
US7572592B2 (en) 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
US8216791B2 (en) 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
US20100203569A1 (en) 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
ES2865148T3 (es) 2014-03-13 2021-10-15 Univ Basel Ligandos de carbohidratos que se unen a los anticuerpos IgM contra la glucoproteína asociada a mielina
EP3243078A1 (fr) 2015-01-09 2017-11-15 Atonomics A/S Test universel pour déterminer la quantité de médicaments inhibiteurs de tnf et leurs anticorps anti-médicament correspondants
EP3318877A1 (fr) * 2015-07-30 2018-05-09 Euroimmun Medizinische Labordiagnostika AG Immunodétection diagnostique d'autoanticorps contre des gangliosides
HK1252262A1 (zh) 2015-09-16 2019-05-24 巴塞尔大学 结合抗糖鞘脂糖蛋白表位抗体的碳水化合物配体
WO2017175003A1 (fr) * 2016-04-08 2017-10-12 Axis-Shield Diagnostics Limited Dosage amélioré d'agglutination de particules
US11119096B2 (en) 2016-07-08 2021-09-14 W. Health L.P. Universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003375A1 (fr) * 1991-08-09 1993-02-18 Washington University Auto-anticorps et leurs cibles utilises dans le diagnostic de neuropathies peripheriques

Also Published As

Publication number Publication date
WO2002018950A1 (fr) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2002305941A1 (en) Quantitative assay for the simultaneous detection and speciation of bacterial infections
AU2002351239A1 (en) Antibody to latent membrane proteins and uses thereof
HUP0500444A3 (en) Hcv antigen/antibody combination assay
AUPS159702A0 (en) Molecular detection and assay by magneto-thermal biochip micro-assay
EP1572077A3 (fr) Utilisations d'anticorps 8h9 monoclonaux
AU2001288431A1 (en) Detection of anti-glycolipid antibodies by latex agglutination assay
AU2002254511A1 (en) Multiple simultaneous antigen detection by immunohistochemistry
AU2003220079A1 (en) Uses of monoclonal antibody 8h9
AU2002222157A1 (en) Yeast-based assays involving gpcrs
AU2002349870A1 (en) Direct serum lipids assays for evaluation of disease states
AU2001236141A1 (en) Immunoassay and diagnostic reagent for malaria
AU2003242106A1 (en) Detection kit, assay plate to be used therein, detection method, evaluation method, polyclonal antibody of frog vitellogenin and procss for producing the same
AU2001232132A1 (en) Novel assay
AU2001267922A1 (en) Method of assaying the function of fc fragment of antibody
AU2002221132A1 (en) Novel antibody
AU2002321899A1 (en) Detection of differential expression of protein using gel-free proteomics
AU2002241185A1 (en) Quantitative detection of the conformation changes of p-glycoprotein
AU4431601A (en) Protein kinase assay
AUPQ743300A0 (en) Separation of avian antibodies
AU2001240793A1 (en) Novel assay
GB0328892D0 (en) Positive signal assay for analytes
AU4587500A (en) Augmented agglutination assay
EP1222210A4 (fr) Methode de dosage immunologique servant a detecter des anticorps d'une maladie coeliaque
AU2003217962A1 (en) Detection of proteins interactions
AU2001261133A1 (en) Detection of antibodies to gangliosides